PHASE I AND PHASE II METABOLISM Flashcards
1
Q
What is metabolism
A
Converting to a less pharmacologically active substance
- May end up being more active
- May end up being toxic/carcinogenic
2
Q
Phase I metabolism
A
- Convert compount to more polar hydrophilic by adding or unmasking a functional group (-OH, -SH, -NH2, -COOH)
- If sufficiently polar they may be excreted in the urine
- May need to undergo phase 2 metabolism
3
Q
Phase II metabolism
A
- Conjugation with endogenous substance = Increase aqueous solubility
- Conjugation with glucuronice, sulfate, acetate, amino acid
4
Q
Phase I reactions
A
- Oxidation, reduction, hydrolytic cleavage, alkylation, dealkylation, ring cyclization, n-carboxylation, dimerization, transamidation, isomerisation, decarboxylation
5
Q
Cytochrome P450
A
- Absorbs light at 450nm when complexed with CO
- Hemoprotein containing iron atom alternating between Fe2+ and Fe3+
- Electron acceptor
- 18 families and 43 subfamilies
- Catalyses reactions to split molecular oxygen where one is introduced into drug and the other leaves as water
- CYP3A4 is responsible for most drugs metabolism
6
Q
Flavin containing monooxygenase system
A
- Mainly in liver but may be in gut + lungs
- Located in SER (smooth endoplasmic reticulum)
- Oxidises compounds containing sulfur and nitrogen
- Use NADH and NADPH as cofactors
1. Drug-H+O2+NADPH+H+>Drug-OH+NADP+H2O
7
Q
Structures prone to reduction
A
By reductase: - Nitro - Azo - Carbonyl By hydrolysis (by esterases and peptidases): - Esters - Amide
8
Q
Structures prone to oxidation
A
- N-methyl
- Aromatic rings
- Terminal positions of alkyl chains
- Least hindered position of alicyclic rings
9
Q
Epoxide formation
A
For benzene, two routes:
- Hydride shift where para position to R is favoured = more hydrophilic/more capable of being conjugated in phase 2
- Epoxide hydrolase converts to a diol = more soluble in water and gets excreted in urine
- Epoxides are alkylating agents making them toxic
- Neighbouring carbons to O are very electrophilic allowing nucleobases and nucleophilic bases to react
- Breaking these bonds are difficult
- Can lead to mutations-cancers/other diseases
10
Q
NAPQI
A
Unwanted product formed by metabolism of paracetamol
- Conjugated ketone / alpha beta unsaturated ketone
- very electrophilic
- reacts strongly with nucleophiles
- can alkylate nucleophiles
- N7 of guanine can react
- Rearomatisation of that ring system makes C-N bond stronger and more difficult to remove
11
Q
Glucuronidation
A
- By UDP-glucuronosyltransferase
- On -OH, -SH, -NH2, -COOH groups
- Products often excreted in bile (may enter enterohepatic circulation)
- Can occur with amines, amides and sulfonamides
12
Q
Sulfoconjugation
A
- Facilitated by sulfotransferases
- For phenols, alcohols, amines and thiols
- Sulfation and glucuronidation are competing pathways
13
Q
Acetylation
A
- Facilitated by N-acetyltransferases
- requires cofactor acetly-coA
- Common reaction for aromatic amines and sulfonamides
- Takes place in liver
- acetyl-sulfonamide may be less soluble than parent compound causing renal toxicity due to precipitation in kidneys
14
Q
Amino acid conjugation
A
- ATP dependent acetyl coA synthetase and CoASH forms active AMP-drug coA-drug
- This then reacts with amino acid by N-acetylation
15
Q
Glutathione
A
- Conjugated by glutathione-S-transferase
- Removes potentially toxic compounds
- Conjugated compound attacked by peptidase forming cysteine
- This can be further acetylated for form N-acetylcysteine conjugate
- Can react with NAPQI, Epoxodes, Alkyl halides, alpha beta unsaturated groups